Monitoring of viral susceptibility: New challenges with the development of influenza NA inhibitors

Reviews in Medical Virology

Volumn 10, Issue 1, 2000, Pages 45-55

  Tisdale, Margaret ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; RIMANTADINE; SIALIDASE INHIBITOR; VIRUS ANTIGEN; VIRUS SIALIDASE;

CYTOPATHOGENIC EFFECT; DRUG MONITORING; INFLUENZA VIRUS; REVIEW; VIRUS INHIBITION;

ANTIVIRAL AGENTS; DRUG RESISTANCE, MICROBIAL; ENZYME INHIBITORS; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MICROBIAL SENSITIVITY TESTS; NEURAMINIDASE;

EID: 0033961667     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1654(200001/02)10:1<45::AID-RMV265>3.0.CO;2-R     Document Type: Review

References (7)

1. Bauer DJ, St Vincent L, Kempe CH, et al. Prophylaxis of smallpox with methisazone. Am J Epidemiol 1969; 90: 130-145.
2. Kaufman HE. Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine. Proc Soc Exp Biol Med 1962; 109: 251-252.
3. Davies WL, Grunert RR, Hall RG, et al. Antiviral activity of 1-adamantanamine (amantadine). Science 1964; 144: 862-863.
4. Melnick JL, Drowther D, Barrera-Oro J. Rapid development of drug-resistant mutants of poliovirus. Science 1961; 134: 557.
5. Appleyard G, Way HJ. Thiosemicarbazoneresistant rabbitpox virus. Br J Exp Pathol 1966; 47: 144-151.
6. Buthala DA. Cell culture studies on antiviral agents: action of cytosine arabinoside and some comparison with 5-iodo-2-deoxyuridine. Proc Soc Exp Biol Med 1964; 115: 69-77.
7. Oxford JS, Logan IS, Potter CW. In vivo selection of an influenza A2 strain resistant to amantadine. Nature 1970; 226: 82-83.